SESSION 2: CLINICAL PRACTICE AND POLICY

Clinical Practice and Policy

Panel:
Representatives from:

• NHS England
• Scottish Government
• General Pharmaceutical Council
• Consultant eating disorder specialists
• General Practitioners

Discussion Topic:
Exploring the current challenges and considerations for clinical practice and health policy in relation to GLP-1 therapy.

Key Themes:

• Clinical implementation challenges across primary and secondary care
• Regulatory and professional standards in prescribing and monitoring
• Cross-system coordination between NHS bodies and services
• Guidance development and policy implications for safe practice
• Workforce readiness and training needs in GP and specialist settings

Session Format:
Panel discussion followed by audience Q&A.